Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
![Carto 3, Biosense Webster, CartoUnivu](/sites/default/files/styles/content_feed_large/public/field/image/Carto%203%20System%20PIU%20Map.jpg?itok=7siwBSU1)
![Nanostim, leadless pacemaker](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Nanostim_%20nanostim%20wirless%20pacemaker%20technical%20image.jpg?itok=dMI8Zo7R)
June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
![](/sites/default/files/styles/content_feed_large/public/field/image/FIRM%20rotor%20mapping.jpg?itok=89V2oNmq)
May 16, 2013 — New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and ...
May 13, 2013 – New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of ...
![](/sites/default/files/styles/content_feed_large/public/field/image/episense-tip_0.jpg?itok=P0AUexDk)
May 14, 2013 — nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
May 14, 2013 — Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool ...
![Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Atritech_Watchman%20device%20sizes.jpg?itok=Ek8xC-Q5)
May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrat ...
May 13, 2013 — Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human) ...
April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner ...
April 4, 2013 — Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
April 4, 2013 — iRhythm Technologies Inc. announced clinical study findings showing that use of the Zio Patch resulted ...
![Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation](/sites/default/files/styles/content_feed_large/public/field/image/Watchman_1.jpg?itok=0APGOHhk)
March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co ...
![](/sites/default/files/styles/content_feed_large/public/field/image/ACP_Oblique_W_Highres_highres.jpg?itok=pYg7a9Tl)
March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company ...